These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 28214851)
1. Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1. Ray U; Roy SS; Chowdhury SR Cell Physiol Biochem; 2017; 41(2):795-805. PubMed ID: 28214851 [TBL] [Abstract][Full Text] [Related]
2. PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells. Sun L; Li H; Chen J; Iwasaki Y; Kubota T; Matsuoka M; Shen A; Chen Q; Xu Y J Cell Sci; 2013 Sep; 126(Pt 17):3939-47. PubMed ID: 23843607 [TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus. Ha JH; Ward JD; Radhakrishnan R; Jayaraman M; Song YS; Dhanasekaran DN Oncotarget; 2016 Jun; 7(25):37664-37679. PubMed ID: 27166196 [TBL] [Abstract][Full Text] [Related]
4. SIRT1 deacetylates KLF4 to activate Claudin-5 transcription in ovarian cancer cells. Zhang X; Chen J; Sun L; Xu Y J Cell Biochem; 2018 Feb; 119(2):2418-2426. PubMed ID: 28888043 [TBL] [Abstract][Full Text] [Related]
5. SIRT1-ZEB1-positive feedback promotes epithelial-mesenchymal transition process and metastasis of osteosarcoma. Yu XJ; Guo XZ; Li C; Chong Y; Song TN; Pang JF; Shao M J Cell Biochem; 2019 Mar; 120(3):3727-3735. PubMed ID: 30304565 [TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma. Burkhalter RJ; Westfall SD; Liu Y; Stack MS J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151 [TBL] [Abstract][Full Text] [Related]
7. Rikkunshito attenuates induction of epithelial-mesenchymal switch via activation of Sirtuin1 in ovarian cancer cells. Kanda R; Miyagawa Y; Wada-Hiraike O; Hiraike H; Fukui S; Nagasaka K; Ryo E; Fujii T; Osuga Y; Ayabe T Endocr J; 2020 Apr; 67(4):379-386. PubMed ID: 31839623 [TBL] [Abstract][Full Text] [Related]
8. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells. Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660 [TBL] [Abstract][Full Text] [Related]
9. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells. Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618 [TBL] [Abstract][Full Text] [Related]
10. Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition. Lee M; Kim DW; Yoon H; So D; Khalmuratova R; Rhee CS; Park JW; Shin HW J Allergy Clin Immunol; 2016 Jan; 137(1):87-98.e7. PubMed ID: 26342525 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1. Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025 [TBL] [Abstract][Full Text] [Related]
12. Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells. Cui Y; Li J; Zheng F; Ouyang Y; Chen X; Zhang L; Chen Y; Wang L; Mu S; Zhang H Med Sci Monit; 2016 Feb; 22():380-6. PubMed ID: 26847404 [TBL] [Abstract][Full Text] [Related]
13. A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. Sun L; Li H; Chen J; Dehennaut V; Zhao Y; Yang Y; Iwasaki Y; Kahn-Perles B; Leprince D; Chen Q; Shen A; Xu Y J Natl Cancer Inst; 2013 Jun; 105(12):887-98. PubMed ID: 23704280 [TBL] [Abstract][Full Text] [Related]
14. Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells. Liang L; Liu X; He J; Shao Y; Liu J; Wang Z; Xia L; Han T; Wu P Biochimie; 2019 Jul; 162():107-115. PubMed ID: 30876970 [TBL] [Abstract][Full Text] [Related]
15. From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate. Chou HC; Wen LL; Chang CC; Lin CY; Jin L; Juan SH Toxicol Sci; 2017 Dec; 160(2):217-229. PubMed ID: 28973641 [TBL] [Abstract][Full Text] [Related]
16. FSCN1 Promotes Epithelial-Mesenchymal Transition Through Increasing Snail1 in Ovarian Cancer Cells. Li J; Zhang S; Pei M; Wu L; Liu Y; Li H; Lu J; Li X Cell Physiol Biochem; 2018; 49(5):1766-1777. PubMed ID: 30231243 [TBL] [Abstract][Full Text] [Related]
17. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling. Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157 [TBL] [Abstract][Full Text] [Related]
19. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition. Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998 [TBL] [Abstract][Full Text] [Related]
20. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer. Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]